ICM
NGVT icon

Invenomic Capital Management’s Ingevity NGVT Stock Holding History

Invenomic Capital Management’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-68,059
Closed -$2.77M – 190
2024
Q4 		$2.77M Buy
+68,059
New +$2.83M 0.13% 136
2024
Q3 		– Sell
-13,202
Closed -$577K – 171
2024
Q2 		$577K Sell
13,202
-31,245
-70% -$1.51M 0.03% 158
2024
Q1 		$2.12M Sell
44,447
-2,137
-5% -$96K 0.11% 127
2023
Q4 		$2.2M Buy
+46,584
New +$1.93M 0.1% 144
2022
Q3 		– Sell
-31,653
Closed -$2M – 176
2022
Q2 		$2M Buy
31,653
+22,717
+254% +$1.48M 0.14% 122
2022
Q1 		$573K Buy
+8,936
New +$598K 0.06% 145
2020
Q3 		– Sell
-7,245
Closed -$381K – 167
2020
Q2 		$381K Buy
+7,245
New +$344K 0.28% 103

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Invenomic Capital Management's NGVT Position: Q1 2025 in Review

Invenomic Capital Management sold out of Ingevity (NGVT) in Q1 2025, closing a stake of 68,059 shares — an estimated $2.77M sold.

Invenomic Capital Management first reported a position in NGVT in Q2 2020 and held it in 7 quarters. The position peaked at $2.77M in Q4 2024. 281 funds tracked by Wall St. Rank hold NGVT as of Q1 2025.

  • Invenomic Capital Management reported no remaining Ingevity position as of Q1 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 68,059 Ingevity shares in Q1 2025, an estimated $2.77M.
  • Invenomic Capital Management first reported a position in Ingevity in Q2 2020 and held it in 7 quarters.
  • Invenomic Capital Management's Ingevity position peaked at $2.77M in Q4 2024.
  • 281 funds tracked by Wall St. Rank held Ingevity as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.